ABOUT US
We are committed to optimize the treatment experience and address unmet needs for patients with autoimmune and chronic inflammatory conditions through novel topical therapies tailored for fast relief of symptoms in formulations that patients prefer to use in daily routines. Read more about MC2 Therapeutics.
Platform
Our PAD™ Technology offers a number of unique advantages in the development of potent innovative new topical therapies for auto-immune and inflammatory conditions. Read more about our platform.
Pipeline
Inflammatory conditions on the skin or in the eyes may negatively affect the appearance and quality of life, why patients are highly involved in the choice of therapy. Topical therapies need to provide the three essentials in a single product: (i) High efficacy; (ii) high tolerability and (iii) high adherence (patient preference) Read more about our pipeline.
